Autoregulation of Glomerular Filtration Rate
Autoregulation of Glomerular Filtration Rate
批准号:
7913926
负责人:
ROLAND C BLANTZ
金额:
$10.6万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-01 至 2011-08-31
关键词:
AcuteAdenosineAffectAngiotensin IIAnimalsBiological AssayBlood PressureBlood VesselsBlood flowCategoriesCellsChronicCoinContralateralDOCADependenceDistalElementsEnvironmentEnzymesEquilibriumEventExhibitsExtraglomerular Mesangial CellFeedbackGenerationsGlomerular Filtration RateGrowthHandHenle&aposs loopHomeostasisHormonalHourHypertensionImaging TechniquesIn VitroIndividualJuxtaglomerular ApparatusKidneyKnowledgeLearningLifeLiquid substanceMacula densaMeasuresMediatingMediator of activation proteinMetabolicMethodsMicropunctureModelingModificationNephrectomyNephronsNitric OxideOperating SystemPTGS2 genePhasePhysiologicalPhysiological ProcessesPhysiologyPregnancyPreparationProcessRadioimmunoassayRattusRegulationResearchResistanceRoleSignal TransductionSodium ChlorideStimulusStructure of glomerular mesangiumSystemTechniquesTestingTimeTubular formationUltrafiltrationVariantVascular resistanceWestern BlottingWorkarteriolebasedesensitizationextracellularfallsin vivoinsightinterestkidney vascular structuremaculameetingsnovelparacrinepreventreceptorresearch studyresponsesalt balancetransmission processuptakevasoconstriction
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The role of the kidney in volume homeostasis critically depends upon coordination of glomerular ultrafiltration (GFR) and tubular reabsorption. This is achieved through the coordinated actions of glomerulotubular balance (GTB) and the tubuloglomerular feedback (TGF) system. Whenever there is a change in concentration of salt in tubular fluid reaching the MD, TGF elicits a reciprocal change in SNGFR. However, the TGF system must adapt over time to sustained changes in MD NaCl concentration and delivery in order to maintain homeostatic efficiency of TGF. Resetting of TGF or 'temporal adaptation' of TGF does occur by changes in nephron blood flow, afferent arteriolar resistance and alteration in SNGFR leading to a new relationship between the MD signal and the efferent vascular response. The acute TGF response occurs within 30 seconds. The immediateTGF response is associated with ATP release from the MD and is mediated by ATP and/or adenosine, possibly via the Al receptor. A second sustained phase of vasoconstriction continues for 30-40 minutes primarily mediated by adenosine. A third phase of temporal adaptation of TGF occurs after 30-40 minutes and requires activity of NOS-1 and COX-2 products, probably as modulators. The mechanisms of temporal adaptation of TGF remain to be elucidated. We will utilize micropuncture techniques, the in vitro microperfused MD/ afferent arteriole-glomerulus's preparation, in vitro proximal tubules and enzyme assays, radioimmunoassays, Western blots and metabolic assessments to answer the following pertinent questions: Specific aim #1- We will determine using in vivo and in vitro experiments whether temporal adaptation occurs a) at the level of modification of the MD NaCl signal, b)suppression of transmission of the TGF signal, probably via the extraglomerular mesangial cells to the afferent arteriole and glomerulus or c) via alterations in the responsiveness of efferent vascular resistance. Specific aim #2 - We propose that tubular reabsorption adapts and increases secondarily in response to the major changes in filtered load after TGF adaptation and these changes depend upon hormonal influences which mediate and modulate TGF activation and temporal adaptation, e.g., adenosine, ATP, angiotensin II (All) and NO from NOS-1. Specific aim #3 - We will examine 3 conditions of TGF resetting or temporal adaptation which are 1) variations in dietary NaCl and chronic volume expansion (DOCA and high NaCl), 2) acute volume expansion and 3) following contralateral nephrectomy. Do these conditions permit and exhibit further temporal adaptation of TGF? What are the physiologic consequences of preventing temporal adaptation of TGF in the conditions described? Temporal adaptation of TGF is required to maintain homeostatic efficiency of TGF with transitions in physiologic conditions. TGF adaptation is a requirement for a variety of conditions in life; normal growth, changes in dietary NaCl, loss of nephron mass, alterations in proximal tubular reabsorption, acute hypertension, etc. Defining the mechanism of temporal adaptation of TGF is required for complete understanding of long term kidney contribution to volume homeostasis. These studies will also define the role of purinergic (ATP) and adenosine mediated TGF during all 3 phases of TGF.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Angiotensin Adrenergic Interactions in the Kidney
-
批准号:7793236
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:ROLAND C BLANTZ
-
依托单位:
Angiotensin Adrenergic Interactions in the Kidney
-
批准号:7905795
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:ROLAND C BLANTZ
-
依托单位:
Angiotensin Adrenergic Interactions in the Kidney
-
批准号:8195902
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:ROLAND C BLANTZ
-
依托单位:
Angiotensin Adrenergic Interactions in the Kidney
-
批准号:8391105
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:ROLAND C BLANTZ
-
依托单位:
AUTOREGULATION OF GLOMERULAR FILTRATION RATE
-
批准号:6140322
-
项目类别:
-
资助金额:$6.44万
-
财政年份:1999
-
负责人:ROLAND C BLANTZ
-
依托单位:
AUTOREGULATION OF GLOMERULAR FILTRATION RATE
-
批准号:6083834
-
项目类别:
-
资助金额:$1.61万
-
财政年份:1999
-
负责人:ROLAND C BLANTZ
-
依托单位:
HYPERTENTION
-
批准号:6627330
-
项目类别:
-
资助金额:$34.68万
-
财政年份:1996
-
负责人:ROLAND C BLANTZ
-
依托单位:
Hypertension Training Grant
-
批准号:8526490
-
项目类别:
-
资助金额:$24.86万
-
财政年份:1996
-
负责人:ROLAND C BLANTZ
-
依托单位:
HYPERTENTION
-
批准号:6490332
-
项目类别:
-
资助金额:$33.06万
-
财政年份:1996
-
负责人:ROLAND C BLANTZ
-
依托单位:
Hypertension
-
批准号:6755925
-
项目类别:
-
资助金额:$18.2万
-
财政年份:1996
-
负责人:ROLAND C BLANTZ
-
依托单位:
HYPERTENSION
-
批准号:2649470
-
项目类别:
-
资助金额:$16.94万
-
财政年份:1996
-
负责人:ROLAND C BLANTZ
-
依托单位:
HYPERTENSION
-
批准号:7290294
-
项目类别:
-
资助金额:$36.74万
-
财政年份:1996
-
负责人:ROLAND C BLANTZ
-
依托单位:
HYPERTENSION
-
批准号:7481028
-
项目类别:
-
资助金额:$36.74万
-
财政年份:1996
-
负责人:ROLAND C BLANTZ
-
依托单位:
Hypertension Training Grant
-
批准号:8281420
-
项目类别:
-
资助金额:$33.23万
-
财政年份:1996
-
负责人:ROLAND C BLANTZ
-
依托单位:
HYPERTENSION
-
批准号:7904245
-
项目类别:
-
资助金额:$13.72万
-
财政年份:1996
-
负责人:ROLAND C BLANTZ
-
依托单位:
HYPERTENTION
-
批准号:6901921
-
项目类别:
-
资助金额:$35.36万
-
财政年份:1996
-
负责人:ROLAND C BLANTZ
-
依托单位:
HYPERTENSION
-
批准号:7661501
-
项目类别:
-
资助金额:$37.03万
-
财政年份:1996
-
负责人:ROLAND C BLANTZ
-
依托单位:
HYPERTENSION
-
批准号:2752376
-
项目类别:
-
资助金额:$18.19万
-
财政年份:1996
-
负责人:ROLAND C BLANTZ
-
依托单位:
HYPERTENSION
-
批准号:2857604
-
项目类别:
-
资助金额:$20.77万
-
财政年份:1996
-
负责人:ROLAND C BLANTZ
-
依托单位:
HYPERTENSION
-
批准号:6138963
-
项目类别:
-
资助金额:$19.09万
-
财政年份:1996
-
负责人:ROLAND C BLANTZ
-
依托单位:
国内基金
海外基金
基于ADK/Adenosine调控DNA甲基化探讨“利湿化瘀通络”法对2型糖尿病肾病足细胞裂孔膜损伤的干预机制研究
-
批准号:82074359
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:安晓飞
-
依托单位:
细胞外腺苷(Adenosine)作为干细胞旁分泌因子的生物学鉴定和功能分析
-
批准号:81570244
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2015
-
负责人:丁兆平
-
依托单位:
Adenosine诱导A1/A2AR稳态失衡启动慢性低灌注白质炎性损伤及其机制
-
批准号:81171113
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2011
-
负责人:黄文
-
依托单位: